Drugs for Parkinson’s Flashcards
what are the adverse effects of levodopa?
N/V, arrhythmias, hypotension, dyskinesias, behavior disturbances
after several years: wearing off reactions or on-off phenomenon
levodopa is contraindicated with ______ inhibitors, as well as Vitamin _____
levodopa is contraindicated with nonspecific MAO inhibitors - cause hypertensive crisis
as well as Vitamin B6 (pyridoxine) - enhances extracerebral metabolism of levodopa
describe the pharmacokinetics of levodopa
oral, plasma t1/2 is 1-3 hours; can also be used as duodenum infusion
metabolized mostly by L-AAD (L-aromatic amino acid decarboxylase) and COMT
absorbed from small intestine/transported by active transport, competitive with aromatic amino acids (high protein meal may reduce peak plasma concentration)
name an inhibitor of peripheral L-AAD, an inhibitor of central COMT, and an inhibitor of peripheral [only] COMT used in combination with levodopa to reduce its metabolism
(so 3 drugs total)
carbidopa: inhibits peripheral L-AAD (L-aromatic amino acid decarboxylase)
tolcapone: inhibits peripheral + central COMT (catechol-O-methyltransferase)
entacapone: inhibits peripheral only COMT
describe the pharmacokinetics of tolcapone vs entacapone
which is preferred?
tolcapone = peripheral + central COMT; oral, plasma t1/2 2-3 hours, metabolized by glucuronidation… note some hepatotoxicity
entacapone = peripheral COMT; oral, plasma t1/2 1-2 hours, metabolized by glucuronidation
however, entacapone is preferred due to no incidence of hepatotoxicity
to which dopamine receptors do the following agonists bind?
a. bromocriptine
b. pramipexole
c. ropinirole
d. rotigotine
how are they used?
bromocriptine: D2
ropinirole: D2
pramipexole: D3
rotigotine: D3 (not very selective)
all used as monotherapy in patients with mild Parkinson’s, or as adjunct to levodopa in patients with advanced disease
which of the following dopamine agonists is an ergot derivative? what is the clinical significance of this?
a. ropinirole
b. bromocriptine
c. rotigotine
d. pramipexole
b. bromocriptine: binds D2, ergot derivative (contains lysergic acid moiety)
because of this, behavioral disturbances (hallucinations, confusion) are more severe
also, unique side effects (ergot causes vasoconstriction): fibrosis, erythromelalgia, digital vasospasm
therefore, rarely used
which of the following dopamine agonists is metabolized by CYP1A2 in the liver?
a. ropinirole
b. bromocriptine
c. rotigotine
d. pramipexole
a. ropinirole: binds D2
therefore, other drugs that are also metabolized by CYP1A2 in the liver may reduce clearance
which of the following dopamine agonists undergoes renal clearance?
a. ropinirole
b. bromocriptine
c. rotigotine
d. pramipexole
d. pramipexole: binds D3, excreted largely unchanged by renal clearance
all others are primarily metabolized by liver
sort the following dopamine agonists by increasing half life:
a. ropinirole
b. bromocriptine
c. rotigotine
d. pramipexole
- bromocriptine: 3-7 hours
- ropinirole: 6 hours
- pramipexole: 8 hours, renal clearance
- rotigotine: once-daily transdermal patch
what is the MAO and clinical use of apomorphine?
dopamine agonist at D2/3/4/5, nonergot
used as rescue treatment in levodopa-induced “off” akinesia episodes in patients with advanced Parkinson’s
subcutaneous injection, effects within 10 mins
dopamine agonist used as rescue treatment in levodopa-induced “off” akinesia episodes in patients with advanced Parkinson’s
apomorphine: dopamine agonist at D2/3/4/5, nonergot
subcutaneous injection, effects within 10 mins
with what class of drugs is apomorphine contraindicated? why?
dopamine agonist used as rescue treatment in levodopa-induced “off” akinesia episodes
contraindicated with antiemetics of 5HT3 serotonin receptor class —> causes severe hypotension and loss of consciousness
what is the MAO and clinical use of rasagiline and selegiline?
irreversible MAO-B (monoamine oxidase B) inhibitors used to treat Parkinson’s - monotherapy if mild, adjunct if advanced
both taken orally (t1/2 2-3 hours) and metabolized in liver
what additional side effects can be caused by selegiline as compared to rasagiline and why?
both MAO-B inhibitors used to treat Parkinson’s
selegiline can cause insomnia and anxiety because it’s metabolites include amphetamine and methamphetamine